Diet Pills - Xenical and Meridia

Study Origin: Centre for Obesity Research and Education, Monash University, Victoria.

Title: Weight loss medications--where do they fit in?

Researchers: Dixon, JB

Objective: This article discusses the role of medications in the overall management of obesity.

Discussion: Management needs to be multifaceted, aiming to alter the patient and family micro-environment to one favouring better weight control through sustainable behavioural changes to physical activity and diet. Weight loss medications may provide additional benefit. Currently we have only two medications suitable for long term therapy--orlistat (trade name Xenical) and sibutramine (trade name Meridia). Sibutramine, which acts centrally to suppress appetite, has shown efficacy for up to 2 years. Orlistat, a lipase inhibitor, reduces fat absorption and has been shown to reduce and maintain weight for up to 4 years. The effect of these medications is modest, generally providing less than 5 kg weight loss when compared with placebo. Patients need to have realistic expectations and understand the benefits of sustained modest weight loss. It is important that weight loss diet pill medications are prescribed in combination with lifestyle modification.